University of Central Florida Research Foundation Assigned Patent for Cerium Oxide Nanoparticle-based Device for Detection of Reactive Oxygen Species and Monitoring of Chronic Inflammation
By Targeted News Service
ALEXANDRIA, Va., Aug. 7 -- The University of Central Florida Research Foundation, Orlando, Florida, has been assigned a patent (8,795,731) developed by four co-inventors for a "cerium oxide nanoparticle-based device for the detection of reactive oxygen species and monitoring of chronic inflammation." The co-inventors are Jesus Manuel Perez, Orlando, Florida, Charalambos Kaittanis, Oviedo, Florida, Atul Asati, Orlando, Florida, and Santimukul Santra, Orlando, Florida.
The patent application was filed on Oct. 8, 2010 (12/924,976). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,795,731.PN.&OS=PN/8,795,731&RS=PN/8,795,731
Written by Balkishan Dalai; edited by Jaya Anand.